# Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

> **NCT05219799** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Missouri-Columbia** · enrollment: 72 (estimated)

## Conditions studied

- Obesity
- Vasodilation
- Healthy

## Interventions

- **DRUG:** Propranolol Hydrochloride
- **DRUG:** Isoproterenol
- **DRUG:** Phentolamine Mesylate
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT05219799
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-14
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05219799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05219799, "Sex Disparities in Hypoxic Vasodilation and Impact of Obesity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05219799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*